Issuance of Environmental Assessment and Finding of No Significant Impact Regarding a Proposed License Amendment for Endocyte Incorporated 1205 Kent Avenue Facility, West Lafayette, IN, 51097-51098 [E5-4709]

Download as PDF Federal Register / Vol. 70, No. 166 / Monday, August 29, 2005 / Notices For the Nuclear Regulatory Commission. Kahtan N. Jabbour, Project Manager, Section 2, Project Directorate III, Division of Licensing Project Management, Office of Nuclear Reactor Regulation. [FR Doc. E5–4711 Filed 8–26–05; 8:45 am] BILLING CODE 7590–01–P NUCLEAR REGULATORY COMMISSION [Docket No. 030–35228] Issuance of Environmental Assessment and Finding of No Significant Impact Regarding a Proposed License Amendment for Endocyte Incorporated 1205 Kent Avenue Facility, West Lafayette, IN Nuclear Regulatory Commission. ACTION: Issuance of environmental assessment and finding of no significant impact. AGENCY: FOR FURTHER INFORMATION CONTACT: Gene Bonano, Health Physicist, Decommissioning Branch, Division of Nuclear Materials Safety, Region III, U.S. Nuclear Regulatory Commission, 2443 Warrenville Road, Lisle, Illinois 60532; telephone: (630) 829–9826; fax number: (630) 515–1259; e-mail: gab1@nrc.gov. SUPPLEMENTARY INFORMATION: The Nuclear Regulatory Commission (NRC) is considering issuing a license amendment to Material License No. 13– 32212–01 issued to Endocyte Incorporated (the licensee), to authorize release of its 1205 Kent Avenue facility, West Lafayette, Indiana, for unrestricted use. This Environmental Assessment (EA) is issued in support of this amendment in accordance with the requirements of 10 CFR Part 51. Based on this EA, the NRC has concluded that a Finding of No Significant Impact (FONSI) is appropriate. The amendment will be issued following the publication of this EA/FONSI. I. Environmental Assessment Identification of Proposed Action The NRC staff has prepared this EA to support the Endocyte Incorporated May 26, 2005 (ML052340684) request to release its 1205 Kent Avenue, West Lafayette, Indiana facility for unrestricted use. Endocyte’s 1205 Kent Avenue facility is one of two authorized facilities listed under Material License Number 13–32212–01. The licensee transferred all licensed material from the 1205 Kent Avenue facility to its 3000 Kent Avenue facility. Endocyte VerDate Aug<18>2005 15:17 Aug 26, 2005 Jkt 205001 was granted a license on December 9, 1999, and initiated licensed activities in April 2000 at the 1205 Kent Avenue facility. The 3000 Kent Avenue facility was added to the license on April 4, 2005. Endocyte is authorized to use byproduct material for the research and development of medical products. Endocyte identified three isotopes, which are listed in the license, with half-lives greater than 120 days (hydrogen-3, carbon-14, technetium-99), which had been used at the 1205 Kent Avenue facility. The licensee conducted surveys of the facility and provided information to the NRC to demonstrate that the radiological condition of the building is consistent with criteria specified in 10 CFR Part 20, Subpart E for unrestricted use. No radiological remediation activities are required to complete the proposed action. Need for the Proposed Action The licensee is requesting this license amendment because it no longer plans to conduct NRC-licensed activities at the 1205 Kent Avenue location. The NRC is fulfilling its responsibilities under the Atomic Energy Act to make a decision on the proposed action for decommissioning that ensures that residual radioactivity is reduced to a level that is protective of the public health and safety and the environment. Environmental Impacts of the Proposed Action The NRC staff reviewed the information provided and surveys performed by Endocyte to demonstrate that the release of the 1205 Kent Avenue, West Lafayette, Indiana facility complies with radiological criterial for unrestricted use in 10 CFR 20.1402. Alternatives to the Proposed Action The only alternative to the proposed action of releasing the facility for unrestricted use is to take no action. Under the no-action alternative, the 1205 Kent Avenue facility would remain under an NRC license and would not be released for unrestricted use. Denial of the license amendment request would result in no change to current conditions at the facility. The no-action alternative is not acceptable because it is inconsistent with the NRC’s Timeliness Rule, 10 CFR 30.36 ‘‘Expiration and Termination of Licenses and Decommissioning of Sites and Separate Buildings or Outdoor Areas,’’ which requires licensees who have ceased licensed activities to request termination of their radioactive materials license. This alternative also would impose an unnecessary PO 00000 Frm 00091 Fmt 4703 Sfmt 4703 51097 regulatory burden and limit potential benefits from future uses of the facility. Conclusion The NRC staff concluded that the proposed action is consistent with the NRC’s unrestricted release use specified in 10 CFR Part 20, Subpart E. The staff found that the radiological environmental impacts from the proposed action are bounded by the ‘‘Generic Environmental Impact Statement in Support of Rulemaking on Radiological Criteria for License Termination of NRC-Licensed Nuclear Facilities’’ (NUREG–1496). Additionally, no non-radiological or cumulative impacts were identified. Therefore, the NRC has determined that the proposed action will not have a significant effect on the quality of the human environment. Agencies and Persons Consulted The NRC staff has determined that the proposed action will not affect listed species or critical habitats. Therefore, no further consultation is required under Section 7 of the Endangered Species Act. Likewise, the NRC has determined that the proposed action is not a type of activity that has potential to cause effect on historic properties. Therefore, consultation under Section 106 of the National Historic Preservation Act is not required. The NRC consulted with the Indiana State Department of Health, Indoor and Radiologic Health Division. The Indiana State Department of Health was provided the draft EA for comment on August 1, 2005, and responded back on the same day. The State did not need any additional information, and agreed with the NRC’s finding of No Significant Impact for the License/Facility. II. Finding of No Significant Impact On the basis of the EA in support of the proposed license amendment to release the site for unrestricted use, the NRC has determined that the proposed action will not have a significant effect on the quality of the human environment. Thus, the NRC has determined not to prepare an environmental impact statement for the proposed action. Further Information A copy of this document will be available electronically for public inspection in the NRC Public Document Room or from the Publicly Available Records (PARS) component of the NRC’s document system. From this site, you can access the NRC’s Agencywide Document Access and Management System (ADAMS), which provides text E:\FR\FM\29AUN1.SGM 29AUN1 51098 Federal Register / Vol. 70, No. 166 / Monday, August 29, 2005 / Notices and image files of NRC’s public documents. The following references are available for inspection at NRC’s Public Electronic Reading Room at http:// www.nrc.gov/reading-rm/adams.html (the Public Electronic Reading Room). ADAMS accession numbers are located in parentheses following the reference. 1. Leamon, Christopher P., Ph.D., Radiation Safety Officer, Endocyte Incorporated, letter to U.S. Nuclear Regulatory Commission, May 26, 2005 (ML052340684). 2. Decommissioning Report (Final Status Survey Report), 1205 Kent Avenue, West Lafayette, Indiana, May 26, 2005 (ML052340684). 3. U.S. Nuclear Regulatory Commission, ‘‘Environmental Review Guidance for Licensing Actions Associated with NMSS Programs,’’ NUREG–1748, August 2003. 4. U.S. Nuclear Regulatory Commission, ‘‘Generic Environmental Impact Statement in Support of Rulemaking on Radiological Criteria for License Termination of NRCLicensed Nuclear Facilities,’’ NUREG–1496, August 1994. 5. NRC, NUREG–1757, ‘‘Consolidated NMSS Decommissioning Guidance,’’ Volumes 1–3, September 2003. If you do not have access to ADAMS or if there are problems in accessing the documents located in ADAMS, contact the NRC Public Document Room (PDR) reference staff at (800) 397–4209, (301) 415–4737 or by e-mail to pdr@nrc.gov. Documents may also be viewed electronically on the public computers located at the NRC’s PDR, O 1 F21, One White Flint North, 11555 Rockville Pike, Rockville, MD 20852. The PDR reproduction contractor will copy documents for a fee. Dated at Lisle, Illinois, this 22nd day of August, 2005. James L. Cameron, Chief, Decommissioning Branch, Division of Nuclear Materials Safety, RIII. [FR Doc. E5–4709 Filed 8–26–05; 8:45 am] BILLING CODE 7590–01–P NUCLEAR REGULATORY COMMISSION Notice of Public Meeting of the Interagency Steering Committee on Radiation Standards The meeting will be held from 1 p.m. to 5 p.m. on Tuesday, September 27, 2005. DATES: Nuclear Regulatory Commission and Environmental Protection Agency. ACTION: Notice of public meeting. AGENCIES: 15:17 Aug 26, 2005 Jkt 205001 The meeting will be held in the NRC auditorium, at Two White Flint North, 11545 Rockville Pike, Rockville, Maryland 20852. ADDRESSES: SUMMARY: The U.S. Nuclear Regulatory Commission (NRC) will host a meeting of the Interagency Steering Committee on Radiation Standards (ISCORS) on September, 27, 2005, in Rockville, Maryland. The purpose of ISCORS is to foster early resolution and coordination VerDate Aug<18>2005 of regulatory issues associated with radiation standards. Agencies represented on ISCORS include the NRC, U.S. Environmental Protection Agency, U.S. Department of Energy, U.S. Department of Defense, U.S. Department of Transportation, the Occupational Safety and Health Administration of the U.S. Department of Labor, U.S. Department of Health and Human Services, U.S. Department of Homeland Security. Representatives from the Office of Science and Technology Policy, Defense Nuclear Facilities Safety Board, Office of Management and Budget, State Department, Illinois Bureau of Radiation Safety, and Pennsylvania Bureau of Radiation Protection may be observers at meetings. The objectives of ISCORS are to: (1) Facilitate a consensus on allowable levels of radiation risk to the public and workers; (2) promote consistent and scientifically sound risk assessment and risk management approaches in setting and implementing standards for occupational and public protection from ionizing radiation; (3) promote completeness and coherence of Federal standards for radiation protection; and (4) identify interagency radiation protection issues and coordinate their resolution. ISCORS meetings include presentations by the chairs of the subcommittees and discussions of current radiation protection issues. Committee meetings normally involve pre-decisional intragovernmental discussions and, as such, are normally not open for observation by members of the public or media. ISCORS has adopted the practice of opening one of its meetings each year to all interested members of the public. There will be time on the agenda for members of the public to provide comments. The final agenda for the September meeting will be posted on the ISCORS Web site, http:// www.iscors.org, shortly before the meeting. Participants are encouraged to (1) notify the contact below for preregistration and (2) allow sufficient time for security screening prior to accessing the meeting. FOR FURTHER INFORMATION, CONTACT: Kyung Hee (Jessica) Shin, Office of Nuclear Material Safety and Safeguards, U.S. Nuclear Regulatory Commission, Washington, DC 20555, telephone 301– PO 00000 Frm 00092 Fmt 4703 Sfmt 4703 415–8117; fax 301–415–5397; e-mail KXS1@NRC.GOV. SUPPLEMENTARY INFORMATION: Visitor parking around the NRC building is limited; however, the NRC auditorium is located adjacent to the White Flint Metro Station on the Red Line. Dated at Rockville, MD, this 23rd day of August, 2005. For the Nuclear Regulatory Commission. Scott Flanders, Deputy Director, Environmental and Performance Assessment Directorate, Division of Waste Management and Environmental Protection, Office of Nuclear Material Safety and Safeguards. [FR Doc. E5–4706 Filed 8–26–05; 8:45 am] BILLING CODE 7590–01–P NUCLEAR REGULATORY COMMISSION Notice of Opportunity To Comment on Model Safety Evaluation on Elimination of Typical License Condition Requiring Reporting of Violations of Section 2.C of Operating License Using the Consolidated Line Item Improvement Process Nuclear Regulatory Commission. ACTION: Request for comment. AGENCY: SUMMARY: Notice is hereby given that the staff of the Nuclear Regulatory Commission (NRC) has prepared a model safety evaluation (SE) relating to the elimination of the license condition involving reporting of violations of other requirements (typically in License Condition 2.C) in the operating license of some commercial nuclear power plants. The NRC staff has also prepared a model no significant hazards consideration (NSHC) determination relating to this matter. The purpose of these models is to permit the NRC to efficiently process amendments that propose to delete the reporting requirement. Licensees of nuclear power reactors to which the models apply could then request amendments, confirming the applicability of the SE and NSHC determination to its reactors. The NRC staff is requesting comment on the model SE and model NSHC determination prior to announcing their availability for referencing in license amendment applications. DATES: The comment period expires 30 days from date of publication in the Federal Register. Comments received after this date will be considered if it is practical to do so, but the Commission is able to ensure consideration only for comments received on or before this date. E:\FR\FM\29AUN1.SGM 29AUN1

Agencies

[Federal Register Volume 70, Number 166 (Monday, August 29, 2005)]
[Notices]
[Pages 51097-51098]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E5-4709]


-----------------------------------------------------------------------

NUCLEAR REGULATORY COMMISSION

[Docket No. 030-35228]


Issuance of Environmental Assessment and Finding of No 
Significant Impact Regarding a Proposed License Amendment for Endocyte 
Incorporated 1205 Kent Avenue Facility, West Lafayette, IN

AGENCY: Nuclear Regulatory Commission.

ACTION: Issuance of environmental assessment and finding of no 
significant impact.

-----------------------------------------------------------------------

FOR FURTHER INFORMATION CONTACT: Gene Bonano, Health Physicist, 
Decommissioning Branch, Division of Nuclear Materials Safety, Region 
III, U.S. Nuclear Regulatory Commission, 2443 Warrenville Road, Lisle, 
Illinois 60532; telephone: (630) 829-9826; fax number: (630) 515-1259; 
e-mail: gab1@nrc.gov.

SUPPLEMENTARY INFORMATION: The Nuclear Regulatory Commission (NRC) is 
considering issuing a license amendment to Material License No. 13-
32212-01 issued to Endocyte Incorporated (the licensee), to authorize 
release of its 1205 Kent Avenue facility, West Lafayette, Indiana, for 
unrestricted use. This Environmental Assessment (EA) is issued in 
support of this amendment in accordance with the requirements of 10 CFR 
Part 51. Based on this EA, the NRC has concluded that a Finding of No 
Significant Impact (FONSI) is appropriate. The amendment will be issued 
following the publication of this EA/FONSI.

I. Environmental Assessment

Identification of Proposed Action

    The NRC staff has prepared this EA to support the Endocyte 
Incorporated May 26, 2005 (ML052340684) request to release its 1205 
Kent Avenue, West Lafayette, Indiana facility for unrestricted use. 
Endocyte's 1205 Kent Avenue facility is one of two authorized 
facilities listed under Material License Number 13-32212-01. The 
licensee transferred all licensed material from the 1205 Kent Avenue 
facility to its 3000 Kent Avenue facility. Endocyte was granted a 
license on December 9, 1999, and initiated licensed activities in April 
2000 at the 1205 Kent Avenue facility. The 3000 Kent Avenue facility 
was added to the license on April 4, 2005. Endocyte is authorized to 
use byproduct material for the research and development of medical 
products. Endocyte identified three isotopes, which are listed in the 
license, with half-lives greater than 120 days (hydrogen-3, carbon-14, 
technetium-99), which had been used at the 1205 Kent Avenue facility. 
The licensee conducted surveys of the facility and provided information 
to the NRC to demonstrate that the radiological condition of the 
building is consistent with criteria specified in 10 CFR Part 20, 
Subpart E for unrestricted use. No radiological remediation activities 
are required to complete the proposed action.

Need for the Proposed Action

    The licensee is requesting this license amendment because it no 
longer plans to conduct NRC-licensed activities at the 1205 Kent Avenue 
location. The NRC is fulfilling its responsibilities under the Atomic 
Energy Act to make a decision on the proposed action for 
decommissioning that ensures that residual radioactivity is reduced to 
a level that is protective of the public health and safety and the 
environment.

Environmental Impacts of the Proposed Action

    The NRC staff reviewed the information provided and surveys 
performed by Endocyte to demonstrate that the release of the 1205 Kent 
Avenue, West Lafayette, Indiana facility complies with radiological 
criterial for unrestricted use in 10 CFR 20.1402.

Alternatives to the Proposed Action

    The only alternative to the proposed action of releasing the 
facility for unrestricted use is to take no action. Under the no-action 
alternative, the 1205 Kent Avenue facility would remain under an NRC 
license and would not be released for unrestricted use. Denial of the 
license amendment request would result in no change to current 
conditions at the facility. The no-action alternative is not acceptable 
because it is inconsistent with the NRC's Timeliness Rule, 10 CFR 30.36 
``Expiration and Termination of Licenses and Decommissioning of Sites 
and Separate Buildings or Outdoor Areas,'' which requires licensees who 
have ceased licensed activities to request termination of their 
radioactive materials license. This alternative also would impose an 
unnecessary regulatory burden and limit potential benefits from future 
uses of the facility.

Conclusion

    The NRC staff concluded that the proposed action is consistent with 
the NRC's unrestricted release use specified in 10 CFR Part 20, Subpart 
E. The staff found that the radiological environmental impacts from the 
proposed action are bounded by the ``Generic Environmental Impact 
Statement in Support of Rulemaking on Radiological Criteria for License 
Termination of NRC-Licensed Nuclear Facilities'' (NUREG-1496). 
Additionally, no non-radiological or cumulative impacts were 
identified. Therefore, the NRC has determined that the proposed action 
will not have a significant effect on the quality of the human 
environment.

Agencies and Persons Consulted

    The NRC staff has determined that the proposed action will not 
affect listed species or critical habitats. Therefore, no further 
consultation is required under Section 7 of the Endangered Species Act. 
Likewise, the NRC has determined that the proposed action is not a type 
of activity that has potential to cause effect on historic properties. 
Therefore, consultation under Section 106 of the National Historic 
Preservation Act is not required.
    The NRC consulted with the Indiana State Department of Health, 
Indoor and Radiologic Health Division. The Indiana State Department of 
Health was provided the draft EA for comment on August 1, 2005, and 
responded back on the same day. The State did not need any additional 
information, and agreed with the NRC's finding of No Significant Impact 
for the License/Facility.

II. Finding of No Significant Impact

    On the basis of the EA in support of the proposed license amendment 
to release the site for unrestricted use, the NRC has determined that 
the proposed action will not have a significant effect on the quality 
of the human environment. Thus, the NRC has determined not to prepare 
an environmental impact statement for the proposed action.

Further Information

    A copy of this document will be available electronically for public 
inspection in the NRC Public Document Room or from the Publicly 
Available Records (PARS) component of the NRC's document system. From 
this site, you can access the NRC's Agencywide Document Access and 
Management System (ADAMS), which provides text

[[Page 51098]]

and image files of NRC's public documents. The following references are 
available for inspection at NRC's Public Electronic Reading Room at 
http://www.nrc.gov/reading-rm/adams.html (the Public Electronic Reading 
Room). ADAMS accession numbers are located in parentheses following the 
reference.

    1. Leamon, Christopher P., Ph.D., Radiation Safety Officer, 
Endocyte Incorporated, letter to U.S. Nuclear Regulatory Commission, 
May 26, 2005 (ML052340684).
    2. Decommissioning Report (Final Status Survey Report), 1205 
Kent Avenue, West Lafayette, Indiana, May 26, 2005 (ML052340684).
    3. U.S. Nuclear Regulatory Commission, ``Environmental Review 
Guidance for Licensing Actions Associated with NMSS Programs,'' 
NUREG-1748, August 2003.
    4. U.S. Nuclear Regulatory Commission, ``Generic Environmental 
Impact Statement in Support of Rulemaking on Radiological Criteria 
for License Termination of NRC-Licensed Nuclear Facilities,'' NUREG-
1496, August 1994.
    5. NRC, NUREG-1757, ``Consolidated NMSS Decommissioning 
Guidance,'' Volumes 1-3, September 2003.

    If you do not have access to ADAMS or if there are problems in 
accessing the documents located in ADAMS, contact the NRC Public 
Document Room (PDR) reference staff at (800) 397-4209, (301) 415-4737 
or by e-mail to pdr@nrc.gov. Documents may also be viewed 
electronically on the public computers located at the NRC's PDR, O 1 
F21, One White Flint North, 11555 Rockville Pike, Rockville, MD 20852. 
The PDR reproduction contractor will copy documents for a fee.

    Dated at Lisle, Illinois, this 22nd day of August, 2005.
James L. Cameron,
Chief, Decommissioning Branch, Division of Nuclear Materials Safety, 
RIII.
[FR Doc. E5-4709 Filed 8-26-05; 8:45 am]
BILLING CODE 7590-01-P